Pharmasset, Inc. · Princeton, NJ United States (NASDAQ: VRUS)
| 303-A College Rd. East | Phone: 609-613-4100 |
| Princeton, NJ | Fax: 609-613-4150 |
| 08540 | |
| United States | 
Map This Company |
Pharmasset, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Pharmasset hopes its drugs go viral on the commercial market. The clinical-stage pharmaceutical company is developing a class of compounds known as nucleoside/tide analogs as oral drug candidates to treat viral infections. The company has a number of candidates in development to treat chronic hepatitis C virus (HCV) infection, a leading cause of liver disease, both in clinical development and preclinical research stages; one such candidate is being developed in collaboration with
Pharmasset, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: VRUS Single Location |
|---|---|
| Fiscal Year-End | September |
| 2011 Employees | 82 |
Executives
14 executives listed for Pharmasset, Inc.'s Princeton, NJ location.
| Chairman | G. Steven Burrill | |
|---|---|---|
| President, CEO, and Director | P. Schaefer Price | |
| CFO | Kurt Leutzinger |